000 01217 a2200361 4500
005 20250517190640.0
264 0 _c20181114
008 201811s 0 0 eng d
022 _a1097-6787
024 7 _a10.1016/j.jaad.2017.11.050
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLin, Brian M
245 0 0 _aStatin use and risk of skin cancer.
_h[electronic resource]
260 _bJournal of the American Academy of Dermatology
_c04 2018
300 _a682-693 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aCarcinoma, Basal Cell
_xchemically induced
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProspective Studies
650 0 4 _aRisk Assessment
650 0 4 _aSkin Neoplasms
_xchemically induced
700 1 _aLi, Wen-Qing
700 1 _aCho, Eunyoung
700 1 _aCurhan, Gary C
700 1 _aQureshi, Abrar A
773 0 _tJournal of the American Academy of Dermatology
_gvol. 78
_gno. 4
_gp. 682-693
856 4 0 _uhttps://doi.org/10.1016/j.jaad.2017.11.050
_zAvailable from publisher's website
999 _c27857512
_d27857512